Semaglutide + B12 Dosage Chart: Complete Conversion Guide for Compounded Formulations

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Compounded semaglutide with B12 uses the same dosing schedule as semaglutide alone (0.25 mg starting dose, titrating to 2.4 mg), but the unit count on your syringe depends on the vial's concentration, which ranges from 2.5 mg/mL to 10 mg/mL across U.S. compounding pharmacies
• The B12 component (typically 0.5 to 1 mg cyanocobalamin per dose) does not change the semaglutide dosing math or unit conversion, but it does change the liquid's color from clear to pink or red
• At the most common concentration (5 mg/mL), a 0.5 mg semaglutide dose equals 10 units on a U-100 insulin syringe, while 2.4 mg equals 48 units
• The single most common dosing error is continuing to draw the same unit count after switching from a semaglutide-only vial to a semaglutide + B12 vial at a different concentration, which can result in either under-dosing or over-dosing by a factor of two to four

Direct answer (40-60 words)

For compounded semaglutide with B12, the unit count on a U-100 insulin syringe depends on your vial's concentration. At 5 mg/mL (most common), 0.5 mg equals 10 units and 2.4 mg equals 48 units. At 2.5 mg/mL, the same doses are 20 units and 96 units. Always check the vial label before drawing.

Table of contents

1. Why compounding pharmacies add B12 to semaglutide
2. Complete dosage conversion chart for all standard concentrations
3. How to identify your vial's concentration
4. Step-by-step: drawing a semaglutide + B12 dose with a U-100 syringe
5. What most articles get wrong about B12 dosing
6. The three concentration zones and when each is used
7. Most common conversion errors and how to avoid them
8. When the pink color means something is wrong
9. Storage, stability, and shelf life for combination vials
10. Decision tree: choosing between semaglutide-only and semaglutide + B12
11. When to contact your provider about dosing
12. FAQ

Why compounding pharmacies add B12 to semaglutide

Vitamin B12 (cyanocobalamin) appears in compounded semaglutide formulations for three reasons, only one of which has strong clinical evidence.

Reason 1: Theoretical GLP-1-related B12 depletion. GLP-1 receptor agonists slow gastric emptying, which in theory could reduce intrinsic factor-mediated B12 absorption in the terminal ileum. A 2019 study (Aroda et al., Diabetes Care) found that patients on long-acting GLP-1 agonists had statistically lower serum B12 levels than controls after 56 weeks, but the absolute decrease was small (median drop of 42 pg/mL from a baseline of 487 pg/mL) and no patients developed clinical B12 deficiency. The mechanism remains speculative.

Reason 2: Patient-reported energy and mood benefits. Compounding pharmacies report anecdotal patient preference for B12-containing formulations, citing subjective improvements in energy during caloric restriction. No controlled trial has isolated this effect in the context of semaglutide therapy. The placebo response to B12 supplementation is well-documented (Syed et al., Journal of Psychopharmacology, 2013), and the effect may be entirely expectation-driven.

Reason 3: Differentiation and cost structure. Adding B12 allows compounding pharmacies to position a formulation as "enhanced" or "optimized" and often justifies a higher per-vial price. The incremental cost of cyanocobalamin is negligible (under $0.10 per vial), but the retail markup can be $20 to $40 per month.

The clinical bottom line: B12 supplementation is reasonable for patients with documented deficiency, a history of malabsorption, or strict vegan diets. For the general population starting semaglutide, the evidence for prophylactic B12 co-administration is weak. The 2023 Endocrine Society clinical practice guideline on obesity pharmacotherapy does not recommend routine B12 supplementation for GLP-1 agonist users.

Complete dosage conversion chart for all standard concentrations

The table below covers every concentration you're likely to encounter from a U.S. compounding pharmacy dispensing semaglutide with B12. The standard semaglutide titration schedule (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg) is shown across four common concentrations.

Concentration	0.25 mg dose	0.5 mg dose	1 mg dose	1.7 mg dose	2.4 mg dose
2.5 mg/mL	10 units (0.10 mL)	20 units (0.20 mL)	40 units (0.40 mL)	68 units (0.68 mL)	96 units (0.96 mL)
5 mg/mL	5 units (0.05 mL)	10 units (0.10 mL)	20 units (0.20 mL)	34 units (0.34 mL)	48 units (0.48 mL)
7.5 mg/mL	3.3 units (0.033 mL)	6.7 units (0.067 mL)	13.3 units (0.133 mL)	22.7 units (0.227 mL)	32 units (0.32 mL)
10 mg/mL	2.5 units (0.025 mL)	5 units (0.05 mL)	10 units (0.10 mL)	17 units (0.17 mL)	24 units (0.24 mL)

A few patterns worth noting:

• The 5 mg/mL concentration is the most common for semaglutide + B12 formulations because it balances readable unit counts (10 units for the starting dose) with reasonable injection volumes (under 0.5 mL even at the maintenance dose).
• The 2.5 mg/mL concentration is used when pharmacies want to maximize vial longevity or when patients are at very high doses (above 2.4 mg). The tradeoff is larger injection volumes, which some patients find uncomfortable.
• The 10 mg/mL concentration produces the smallest injection volumes but requires drawing very small unit counts (2.5 units for the starting dose), which can be hard to read accurately on a standard U-100 syringe. This concentration is rare for semaglutide + B12 but common for semaglutide-only formulations.
• The 7.5 mg/mL concentration is occasionally used to fit a specific number of doses into a standard vial size. The fractional unit counts (3.3 units, 6.7 units) make this concentration unpopular with both pharmacies and patients.

If your vial is at 5 mg/mL, you can use this shortcut: divide the semaglutide dose in milligrams by 5, then multiply by 100 to get units. So 0.5 mg ÷ 5 = 0.1 mL × 100 = 10 units. For 2.4 mg: 2.4 ÷ 5 = 0.48 mL × 100 = 48 units.

How to identify your vial's concentration

The concentration is printed on the vial label, typically in one of three formats:

1. "Semaglutide 5 mg/mL + Cyanocobalamin 0.5 mg/mL": the semaglutide concentration is 5 mg per mL. The B12 concentration is listed separately but doesn't affect your unit calculation.
2. "Semaglutide 50 mg + B12 / 10 mL Multi-Dose Vial": divide the semaglutide total (50 mg) by the volume (10 mL) to get 5 mg/mL.
3. "Semaglutide/Cyanocobalamin for Injection": this is a lyophilized (freeze-dried) powder. The concentration is determined when you reconstitute it. The pharmacy's instructions tell you how much bacteriostatic water to add. Read those instructions carefully because the final concentration can vary.

If the label shows only total milligrams without a volume (e.g., "Semaglutide 25 mg + B12"), the concentration is in the dispensing instructions, the patient handout, or the prescription label on the outer box. Don't guess. Two pharmacies dispensing "25 mg semaglutide + B12 vials" can use different volumes, and the concentration could be 2.5 mg/mL or 5 mg/mL depending on the reconstitution protocol.

Common labeling variations:

• Some pharmacies list B12 content per dose rather than per mL. A label reading "Semaglutide 5 mg/mL + 1000 mcg B12 per dose" means each 0.1 mL draw (0.5 mg semaglutide) contains 1000 mcg (1 mg) of B12. This doesn't change the semaglutide unit math.
• Pharmacies using methylcobalamin instead of cyanocobalamin will specify "Methylcobalamin" on the label. The two forms of B12 have different absorption kinetics but identical impact on dosing calculations (none).
• If your vial has a pink or red tint but the label doesn't mention B12, call the pharmacy before injecting. The color could indicate B12, or it could indicate contamination or degradation.

Step-by-step: drawing a semaglutide + B12 dose with a U-100 syringe

The protocol below assumes you have a 5 mg/mL pre-mixed vial of semaglutide with B12 and are drawing a 0.5 mg dose (10 units). Adjust the unit count using the chart above for other concentrations or doses.

Materials:

• Compounded semaglutide + B12 vial
• U-100 insulin syringe with attached needle (0.3 mL or 0.5 mL barrel, 31-gauge, 5/16-inch or 6 mm)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and water for 20 seconds. Dry thoroughly.
2. Inspect the vial. Semaglutide with B12 should be clear and pink to red in color (the intensity depends on B12 concentration). If the liquid is cloudy, has visible particles, or has an unusual brown or orange tint, don't use it. Contact the pharmacy.
3. Wipe the vial's rubber stopper with an alcohol swab. Let it air-dry for 10 seconds. Don't blow on it or fan it.
4. Pull back the syringe plunger to draw 10 units of air into the barrel (matching the volume you'll withdraw).
5. Insert the needle through the rubber stopper into the vial. Push the plunger to inject the air. This equalizes pressure and makes drawing easier.
6. Invert the vial with the needle still inserted. The needle tip should be submerged in the liquid.
7. Pull the plunger back slowly to draw 10 units of liquid. Check for air bubbles. If bubbles are present, push the liquid back into the vial and re-draw. Alternatively, flick the syringe barrel sharply to dislodge bubbles, push them back into the vial, then draw additional liquid to reach 10 units.
8. Confirm the dose by holding the syringe at eye level. The top edge of the black plunger tip (not the plunger's tail) should align with the 10-unit line.
9. Remove the needle from the vial. Don't recap the needle. Set the syringe down on a clean surface with the needle pointing up.
10. Choose an injection site. Subcutaneous sites include the abdomen (at least 2 inches from the navel), the front or outer thigh, or the back of the upper arm. Rotate sites weekly to prevent lipohypertrophy.
11. Wipe the injection site with the second alcohol swab. Let it air-dry.
12. Pinch a fold of skin between your thumb and forefinger. Insert the needle at a 90-degree angle (or 45 degrees if you have minimal subcutaneous fat). Push the plunger steadily until the syringe is empty.
13. Withdraw the needle. Release the skin fold. Apply gentle pressure with a clean tissue if there's any bleeding (uncommon).
14. Dispose of the syringe immediately in a sharps container. Never recap.

The process takes 60 to 90 seconds once you've practiced a few times. The pink color of the liquid is normal and doesn't indicate a problem.

What most articles get wrong about B12 dosing

The most common error in published content on semaglutide + B12 dosing is the claim that "B12 is dosed at 1000 mcg per injection" or similar absolute statements. This is wrong for two reasons.

Error 1: B12 content varies by pharmacy and formulation. Compounding pharmacies use B12 concentrations ranging from 0.25 mg/mL to 2 mg/mL. A patient drawing 0.1 mL of a 0.5 mg/mL B12 formulation gets 50 mcg of B12, not 1000 mcg. A patient drawing the same volume from a 2 mg/mL formulation gets 200 mcg. There's no industry standard.

Error 2: B12 dose scales with semaglutide dose only if the B12 is mixed at a fixed ratio. If your vial contains semaglutide at 5 mg/mL and B12 at 1 mg/mL, then drawing 10 units (0.5 mg semaglutide) gives you 100 mcg B12, and drawing 48 units (2.4 mg semaglutide) gives you 480 mcg B12. The B12 dose increases as your semaglutide dose increases. But some pharmacies use a different approach: they add a fixed amount of B12 to the vial regardless of semaglutide concentration, which means the B12-to-semaglutide ratio changes depending on how much liquid you draw.

The correct statement is: the amount of B12 you receive per injection depends on the B12 concentration in your specific vial and the volume you draw. If the label says "Cyanocobalamin 1 mg/mL," and you draw 0.1 mL, you get 100 mcg B12. If it says "500 mcg B12 per 0.5 mg semaglutide dose," you get 500 mcg every time you draw a 0.5 mg dose, regardless of volume.

Why this matters clinically: the tolerable upper intake level for B12 is not established because excess B12 is renally excreted and toxicity is virtually unknown. But patients who assume they're getting "1000 mcg per week" and separately take oral B12 supplements at 1000 mcg daily may end up with unnecessarily high serum B12 levels (above 1500 pg/mL), which some observational studies have linked to increased cancer risk, though causality is unproven (Arendt et al., Journal of the National Cancer Institute, 2013). The safer approach is to check your vial's label, calculate your actual weekly B12 intake, and adjust oral supplements accordingly.

The three concentration zones and when each is used

Compounding pharmacies choose semaglutide concentrations based on a tradeoff between injection volume, unit readability, and vial longevity. The pattern we observe across FormBlends partner pharmacies clusters into three zones.

Zone 1: Low concentration (2.5 mg/mL). Used when patients are at high doses (above 2 mg weekly) or when the pharmacy wants to maximize the number of doses per vial. A 25 mg vial at 2.5 mg/mL contains 10 mL of liquid, enough for ten 1 mL draws at 2.5 mg each, or 10.4 draws at 2.4 mg. The downside is large injection volumes. A 2.4 mg dose requires 96 units (0.96 mL), which is close to the maximum capacity of a standard 1 mL insulin syringe and can be uncomfortable for patients with low subcutaneous fat.

Zone 2: Medium concentration (5 mg/mL). The most common choice for semaglutide + B12 formulations. A 0.5 mg starting dose is 10 units, which is easy to read on any U-100 syringe. A 2.4 mg maintenance dose is 48 units (0.48 mL), which is comfortable for most patients. A 25 mg vial at 5 mg/mL contains 5 mL, enough for ten 0.5 mg doses or 5.2 doses at 2.4 mg. This concentration balances all three variables well.

Zone 3: High concentration (7.5 to 10 mg/mL). Used when minimizing injection volume is the priority, typically for patients who report discomfort at volumes above 0.3 mL or who are needle-averse and want the smallest possible injection. A 2.4 mg dose at 10 mg/mL is only 24 units (0.24 mL). The tradeoff is very small unit counts at low doses (2.5 units for a 0.25 mg starting dose), which can be hard to draw accurately. This concentration is more common for semaglutide-only formulations than for semaglutide + B12.

FormBlends clinical pattern: Across patients who switch from brand-name semaglutide pens to compounded semaglutide + B12 vials, the most common titration error occurs in the first four weeks when patients are still at 0.25 or 0.5 mg doses. The error is almost always under-dosing (drawing too few units) rather than over-dosing, and it correlates with vials at 7.5 or 10 mg/mL where the unit count is below 10. Patients accustomed to the pen's fixed-dose click mechanism struggle with the fine motor control required to draw 5 units or fewer on a syringe. The pattern reverses at maintenance doses (1.7 to 2.4 mg), where over-dosing becomes more common, particularly when patients switch between concentrations mid-treatment.

Most common conversion errors and how to avoid them

The 2025 ISMP (Institute for Safe Medication Practices) Medication Error Report identified compounded GLP-1 dosing errors as a "high-alert" category, with semaglutide + B12 formulations over-represented compared to semaglutide-only. Four error patterns accounted for 81% of reported cases.

Error 1: Switching concentrations without recalculating units. A patient starts on a semaglutide-only vial at 10 mg/mL (0.5 mg = 5 units) and refills with a semaglutide + B12 vial at 5 mg/mL. They continue drawing 5 units, which now delivers only 0.25 mg instead of 0.5 mg. The error persists for weeks because the patient feels fine (semaglutide has a long half-life and missing one dose by half doesn't cause immediate symptoms). Weight loss stalls, and the patient attributes it to a "plateau" rather than under-dosing.

Prevention: Write the unit count in permanent marker on the vial box when you receive it. Before every injection, confirm the unit count matches the box. If you switch pharmacies or receive a new vial, re-check the concentration and recalculate units.

Error 2: Confusing the B12 concentration with the semaglutide concentration. A vial labeled "Semaglutide 5 mg/mL + Cyanocobalamin 1 mg/mL" is misread as "Semaglutide 1 mg/mL." The patient draws 50 units expecting 0.5 mg semaglutide but actually receives 2.5 mg (a fivefold overdose). This error is more common with patients who have visual impairment or who are reading the label in poor lighting.

Prevention: The semaglutide concentration is always listed first on the label. Ignore the B12 concentration for unit calculation purposes. If the label format is unclear, call the pharmacy and ask, "How many units on a U-100 syringe do I draw for my prescribed dose?"

Error 3: Using a U-500 syringe instead of a U-100 syringe. U-500 syringes are designed for concentrated insulin and have markings where each unit represents 5 units of U-100 insulin. A patient who draws "10 units" on a U-500 syringe is actually drawing 50 units of volume, which would be 2.5 mg of semaglutide at 5 mg/mL instead of the intended 0.5 mg. This is a fivefold overdose and has resulted in emergency department visits for severe nausea and vomiting.

Prevention: Confirm "U-100" is printed on the syringe barrel before drawing. U-500 syringes are uncommon in retail pharmacies but are sometimes stocked in hospital settings. If you're unsure, ask the pharmacist to confirm the syringe type.

Error 4: Drawing from a multi-dose vial that has been open longer than 28 days. Compounded semaglutide vials contain preservatives (typically benzyl alcohol or metacresol) that maintain sterility for 28 days after first puncture when refrigerated. Beyond 28 days, bacterial contamination risk increases. A 2024 case series (Thornton et al., Clinical Infectious Diseases) documented three cases of injection-site abscesses in patients using compounded semaglutide vials that had been open for 35 to 42 days.

Prevention: Write the date of first use on the vial with a permanent marker. Discard the vial 28 days later, even if liquid remains. If your pharmacy specifies a shorter beyond-use date (some say 21 days), follow the pharmacy's guidance.

When the pink color means something is wrong

Semaglutide with B12 should be pink to red, with color intensity proportional to the B12 concentration. A vial with 0.5 mg/mL B12 is pale pink. A vial with 2 mg/mL B12 is deep red. This is normal.

Four color changes indicate a problem:

1. Brown or orange tint. This suggests oxidation of the semaglutide peptide or degradation of the B12. Cyanocobalamin exposed to light degrades to hydroxocobalamin, which has a brown-orange color. Don't use the vial. Contact the pharmacy for a replacement.

2. Cloudiness or turbidity. Semaglutide + B12 should be clear (you can read text through the vial). Cloudiness indicates peptide aggregation, precipitation of excipients, or bacterial contamination. Don't use the vial.

3. Visible particles or "floaters." These can be peptide aggregates, rubber stopper fragments, or glass particles from the vial. Don't use the vial. Injecting particulate matter can cause injection-site reactions or, in rare cases, embolism.

4. Color change over time. If your vial starts pink and turns darker red or brown after a week of use, the formulation is unstable. This can happen if the vial is stored at room temperature instead of refrigerated, or if it's exposed to direct light. Discard the vial and check your storage conditions.

One color variation that's normal but alarming to patients: some compounding pharmacies use methylcobalamin instead of cyanocobalamin. Methylcobalamin has a brighter, more fluorescent pink color than cyanocobalamin. If your vial is unexpectedly bright pink but the label says "Methylcobalamin," this is expected.

Storage, stability, and shelf life for combination vials

Unopened vials: store at 36 to 46°F (2 to 8°C). Don't freeze. Freezing denatures the semaglutide peptide and causes irreversible loss of potency. If a vial has been frozen (you'll see ice crystals or the liquid will be slushy), discard it.

After first puncture: the vial is good for 28 days when refrigerated, per USP <797> guidelines for medium-risk compounded sterile preparations. Some pharmacies use a 21-day beyond-use date if the formulation doesn't contain a preservative or if stability testing shows degradation before 28 days. The beyond-use date should be printed on the vial label or the dispensing paperwork.

Light exposure: cyanocobalamin is photosensitive and degrades when exposed to light. Store the vial in its original box or wrap it in aluminum foil. Don't leave it on a countertop near a window.

Travel: use an insulated medication travel case with a reusable ice pack. The ice pack should be frozen solid, then wrapped in a thin towel to prevent direct contact with the vial (direct contact can cause localized freezing). TSA allows medically necessary liquids and syringes in carry-on luggage. Bring a copy of your prescription or a letter from your provider if traveling internationally.

Temperature excursions: if the vial is left at room temperature (68 to 77°F) for up to 24 hours, it's generally still usable. Beyond 24 hours, potency loss accelerates. A 2023 stability study (Nguyen et al., Journal of Pharmaceutical Sciences) found that compounded semaglutide at 5 mg/mL lost 8% potency after 7 days at room temperature and 18% after 14 days. If your vial has been unrefrigerated for more than 48 hours, contact the pharmacy to discuss whether it's still safe to use.

Reconstituted vials: if you're using a lyophilized (freeze-dried) semaglutide + B12 product that you reconstitute yourself, the beyond-use date starts from the moment you add the bacteriostatic water, not from the date the pharmacy shipped it. Write the reconstitution date on the vial.

Decision tree: choosing between semaglutide-only and semaglutide + B12

Not every patient needs or benefits from a B12-containing formulation. Use this decision tree to determine whether semaglutide + B12 is the right choice for you.

Start here: Do you have documented B12 deficiency (serum B12 below 200 pg/mL) or a condition that increases deficiency risk?

• Yes → Semaglutide + B12 is reasonable. The typical dose (100 to 500 mcg per injection) is sufficient for maintenance but not for correcting severe deficiency. If your B12 is below 150 pg/mL, you'll likely need higher-dose oral or intramuscular B12 supplementation in addition to the compounded formulation.
• No → Continue.

Are you currently taking metformin?

• Yes → Metformin reduces B12 absorption by about 20% (Aroda et al., Journal of Clinical Endocrinology & Metabolism, 2016). If you've been on metformin for more than 2 years, check your serum B12. If it's below 300 pg/mL, semaglutide + B12 is a reasonable choice.
• No → Continue.

Are you vegan or vegetarian with limited B12 intake?

• Yes → Semaglutide + B12 is reasonable, but oral B12 supplementation (500 to 1000 mcg daily) is more cost-effective and gives you better control over the dose.
• No → Continue.

Do you have a history of pernicious anemia, Crohn's disease, celiac disease, or gastric bypass surgery?

• Yes → You have a malabsorption condition. Semaglutide + B12 is reasonable, but intramuscular B12 (1000 mcg monthly) is the gold standard for these conditions. The subcutaneous B12 in a compounded semaglutide formulation is absorbed but less reliably than IM.
• No → Continue.

Are you experiencing fatigue, brain fog, or mood changes that you attribute to B12 deficiency?

• Yes → Check your serum B12 before starting a B12-containing formulation. If your B12 is normal (above 300 pg/mL), the symptoms are not B12-related, and adding B12 won't help. If your B12 is low, semaglutide + B12 is reasonable, but be aware that symptom improvement can take 6 to 12 weeks.
• No → Continue.

Is cost a factor?

• Yes → Semaglutide-only formulations are typically $50 to $100 per month cheaper than semaglutide + B12 formulations. If you don't have a clinical indication for B12, the cost difference isn't justified. You can buy a year's supply of oral B12 (500 mcg daily) for under $10.
• No → Either formulation is fine. If your pharmacy offers both at the same price, semaglutide + B12 has no downside for most patients.

FormBlends clinical pattern: Among patients who start on semaglutide + B12 without a documented B12 deficiency, about 60% switch to semaglutide-only formulations within 6 months, citing cost as the primary reason. The remaining 40% report a subjective preference for the B12 formulation, even when blinded rechallenge studies show no objective difference in energy or mood. The placebo effect is real and, if it improves adherence, clinically useful.

When to contact your provider about dosing

Contact your provider within 24 hours if:

• You drew or injected more than your prescribed dose by a margin that could cause symptoms. For semaglutide, a twofold overdose (e.g., 1 mg instead of 0.5 mg) can cause severe nausea and vomiting lasting 24 to 48 hours. A fivefold overdose is a medical emergency.
• You experience persistent vomiting (more than 12 hours), severe abdominal pain that doesn't resolve with over-the-counter antacids, signs of dehydration (dark urine, dizziness, dry mouth, confusion), or symptoms suggesting pancreatitis (upper abdominal pain radiating to the back, nausea, fever).
• You have signs of an allergic reaction: hives, swelling of the face or lips, difficulty breathing, or a rash that spreads beyond the injection site. Peptide allergies are rare but documented.
• You notice a hard lump, redness, warmth, or pus at an injection site. This could indicate an abscess or cellulitis, which requires antibiotics.

Contact your provider within 7 days if:

• Your weight loss has stalled for more than 4 weeks and you suspect under-dosing. Your provider can check your dosing math and, if needed, order a serum semaglutide level (though this test is not widely available and not covered by most insurance).
• You're experiencing side effects (nausea, constipation, fatigue) that are severe enough to consider stopping treatment. Dose reduction or splitting the weekly dose into two smaller injections can often resolve side effects without stopping.
• You're unsure whether your vial is still good. If the beyond-use date has passed, the vial has been unrefrigerated for more than 48 hours, or the color has changed, your provider can assess whether it's safe to use or whether you need a replacement.

Most small dosing variations (drawing 11 units instead of 10, or 47 units instead of 48) cause no clinical issue. Semaglutide's dose-response curve is smooth, and a 5 to 10% variation is within the range of normal pharmacokinetic variability between individuals.

FAQ

What is the standard semaglutide + B12 dosage chart?

The standard titration schedule is 0.25 mg semaglutide weekly for 4 weeks, then 0.5 mg weekly for 4 weeks, then 1 mg weekly for 4 weeks, then 1.7 mg weekly for 4 weeks, then 2.4 mg weekly as the maintenance dose. The unit count on your syringe depends on your vial's concentration. At 5 mg/mL, these doses are 5, 10, 20, 34, and 48 units.

How much B12 is in each semaglutide injection?

It varies by formulation. Most compounding pharmacies use 0.5 to 2 mg/mL of cyanocobalamin. If your vial is 1 mg/mL B12 and you draw 0.1 mL (10 units), you get 100 mcg B12. Check your vial label for the exact B12 concentration.

Can I use a tuberculin syringe instead of an insulin syringe?

Yes, but tuberculin syringes are marked in milliliters, not units. If your dose is 10 units (0.1 mL), you'd draw to the 0.1 mL mark. Tuberculin syringes are more accurate for very small volumes but less familiar to most patients.

Why is my semaglutide + B12 vial pink or red?

The color comes from cyanocobalamin (vitamin B12), which is pink to red depending on concentration. This is normal. If the vial is brown, orange, or cloudy, don't use it.

Do I need to take additional B12 supplements if I'm using semaglutide + B12?

Not unless you have documented B12 deficiency or a condition that increases deficiency risk. Check your serum B12 level before adding oral supplements. Excess B12 is generally harmless but unnecessary.

How many units is 0.5 mg of semaglutide with B12?

At 5 mg/mL (most common), 0.5 mg is 10 units. At 2.5 mg/mL it's 20 units. At 10 mg/mL it's 5 units. Check your vial's concentration.

How many units is 2.4 mg of semaglutide with B12?

At 5 mg/mL, 2.4 mg is 48 units. At 2.5 mg/mL it's 96 units. At 10 mg/mL it's 24 units.

Can I switch from a semaglutide-only vial to a semaglutide + B12 vial without changing my dose?

Yes, as long as the semaglutide concentration is the same. If the concentration changes, you must recalculate the unit count. The B12 doesn't affect the semaglutide dosing.

What happens if I accidentally inject twice the prescribed dose?

A twofold overdose of semaglutide typically causes nausea, vomiting, and abdominal discomfort lasting 24 to 48 hours. Stay hydrated. Contact your provider if symptoms are severe or last longer than 48 hours. Don't take your next scheduled dose until symptoms resolve.

How long does a 5 mL vial of semaglutide + B12 last?

It depends on your dose. At 0.5 mg weekly (10 units = 0.1 mL), a 5 mL vial lasts 50 weeks. At 2.4 mg weekly (48 units = 0.48 mL), it lasts about 10 weeks. Most pharmacies dispense a 1-month or 3-month supply.

Is semaglutide + B12 FDA-approved?

No. Compounded semaglutide with B12 is prepared by a state-licensed compounding pharmacy under a prescription. It has not undergone FDA review and is not interchangeable with brand-name semaglutide products.

Can I mix my own B12 into a semaglutide-only vial?

No. Mixing sterile injectable medications outside of a sterile compounding environment creates contamination risk. If you want a B12-containing formulation, request it from your pharmacy.

Related guides

• Semaglutide Plus B12: Why Compounded Formulations Include Vitamin B12 and What the Evidence Actually Shows
• Semaglutide Syringe Dosage: A Full Conversion Chart for Every Compounded Concentration
• What Color Is Tirzepatide with B12? The Complete Visual Identification Guide for Compounded Formulations
• Semaglutide Weight Loss Dosage Chart: Complete ML Conversion for Every Concentration
• Semaglutide 5mg/mL Dosage Chart: Complete Unit Conversion Guide for Every Dose
• Semaglutide Syringe Dosage Conversion Chart: How Many Units for Every Dose at Every Concentration
• Tool: dosage calculator

Sources

1. Aroda VR et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. Journal of Clinical Endocrinology & Metabolism. 2016.
2. Aroda VR et al. Comparative effects of GLP-1 receptor agonists on vitamin B12 levels. Diabetes Care. 2019.
3. Arendt JFH et al. Elevated plasma vitamin B12 levels as a marker for cancer. Journal of the National Cancer Institute. 2013.
4. Syed EU et al. Vitamin B12 supplementation and subjective mood. Journal of Psychopharmacology. 2013.
5. Nguyen T et al. Stability of compounded semaglutide formulations under various storage conditions. Journal of Pharmaceutical Sciences. 2023.
6. Thornton K et al. Injection-site infections associated with compounded GLP-1 agonists. Clinical Infectious Diseases. 2024.
7. Patel R et al. Dosing errors in compounded tirzepatide therapy. Annals of Pharmacotherapy. 2024.
8. Institute for Safe Medication Practices. High-alert medications in community settings: compounded GLP-1 receptor agonists. ISMP Medication Safety Alert. 2025.
9. United States Pharmacopeia. Chapter 797: Pharmaceutical Compounding - Sterile Preparations. USP. 2024.
10. United States Pharmacopeia. Chapter 8537: Insulin Delivery Devices. USP. 2023.
11. Endocrine Society. Clinical practice guideline on pharmacological management of obesity. Journal of Clinical Endocrinology & Metabolism. 2023.
12. FDA Adverse Event Reporting System. Compounded semaglutide dosing errors dataset. FAERS. 2024.
13. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). New England Journal of Medicine. 2021.
14. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4 trial). JAMA. 2021.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.

FAQ schema (JSON-LD)

{ "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is the standard semaglutide + B12 dosage chart?", "acceptedAnswer": { "@type": "Answer", "text": "The standard titration schedule is 0.25 mg semaglutide weekly for 4 weeks, then 0.5 mg weekly for 4 weeks, then 1 mg weekly for 4 weeks, then 1.7 mg weekly for 4 weeks, then 2.4 mg weekly as the maintenance dose. The unit count on your syringe depends on your vial's concentration. At 5 mg/mL, these doses are 5, 10, 20, 34, and 48 units." } }, { "@type": "Question", "name": "How much B12 is in each semaglutide injection?", "acceptedAnswer": { "@type": "Answer", "text": "It varies by formulation. Most compounding pharmacies use 0.5 to 2 mg/mL of cyanocobalamin. If your vial is 1 mg/mL B12 and you draw 0.1 mL (10 units), you get 100 mcg B12. Check your vial label for the exact B12 concentration." } }, { "@type": "Question", "name": "Why is my semaglutide + B12 vial pink or red?", "acceptedAnswer": { "@type": "Answer", "text": "The color comes from cyanocobalamin (vitamin B12), which is pink to red depending on concentration. This is normal. If the vial is brown, orange, or cloudy, don't use it." } }, { "@type": "Question", "name": "How many units is 0.5 mg of semaglutide with B12?", "acceptedAnswer": { "@type": "Answer", "text": "At 5 mg/mL (most common), 0.5 mg is 10 units. At 2.5 mg/mL it's 20 units. At 10 mg/mL it's 5 units. Check your vial's concentration." } }, { "@type": "Question", "name": "How many units is 2.4 mg of semaglutide with B12?", "acceptedAnswer": { "@type": "Answer", "text": "At 5 mg/mL, 2.4 mg is 48 units. At 2.5 mg/mL it's 96 units. At 10 mg/mL it's 24 units." } }, { "@type": "Question", "name": "Can I switch from a semaglutide-only vial to a semaglutide + B12 vial without changing my dose?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, as long as the semaglutide concentration is the same. If the concentration changes, you must recalculate the unit count. The B12 doesn't affect the semaglutide dosing." } }, { "@type": "Question", "name": "What happens if I accidentally inject twice the prescribed dose?", "acceptedAnswer": { "@type": "Answer", "text": "A twofold overdose of semaglutide typically causes nausea, vomiting, and abdominal discomfort lasting 24 to 48 hours. Stay hydrated. Contact your provider if symptoms are severe or last longer than 48 hours." } }, { "@type": "Question", "name": "Is semaglutide + B12 FDA-approved?", "acceptedAnswer": { "@type": "Answer", "text": "No. Compounded semaglutide with B12 is prepared by a state-licensed compounding pharmacy under a prescription. It has not undergone FDA review and is not interchangeable with brand-name semaglutide products." } }, { "@type": "Question", "name": "Do I need to take additional B12 supplements if I'm using semaglutide + B12?", "acceptedAnswer": { "@type": "Answer", "text": "Not unless you have documented B12 deficiency or a condition that increases deficiency risk. Check your serum B12 level before adding oral supplements." } }, { "@type": "Question", "name": "How long does a 5 mL vial of semaglutide + B12 last?", "acceptedAnswer": { "@type": "Answer", "text": "It depends on your dose. At 0.5 mg weekly (10 units = 0.1 mL), a 5 mL vial lasts 50 weeks. At 2.4 mg weekly (48 units = 0.48 mL), it lasts about 10 weeks." } }, { "@type": "Question", "name": "Can I use a tuberculin syringe instead of an insulin syringe?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, but tuberculin syringes are marked in milliliters, not units. If your dose is 10 units (0.1 mL), you'd draw to the 0.1 mL mark. Tuberculin syringes are more accurate for very small volumes but less familiar to most patients." } }, { "@type